Usted no se ha autentificado. (Entrar)

Esta cuenta se ha cancelado

Nerte Weber

 

 

In addition, U937 macrophage monolayers infected with MAC strain 101 (serovar 1) were treated with moxifloxacin (0.25 to 8 microg/ml) daily, and the number of intracellular bacteria antibiotics was quantitated after 4 days. Two-drug combinations containing azithromycin ( Zithromax ) were no more active than azithromycin ( Zithromax ) alone. Moxifloxacin, ethambutol, and azithromycin antibiotics ( Zithromax ) were active as single agents in liver, spleen, and blood. Comparative activity of azithromycin ( Zithromax ) and doxycycline against Brucella spp. The combination with streptomycin (14 days, 10 mg/kg/day) did not improve the effect of any of the regimens. acyclovir (i) moxifloxacin (50 mg/kg/day or 100 mg/kg/day), ethambutol (100 mg/kg/day), or a combination of moxifloxacin and ethambutol; or (ii) moxifloxacin (100 mg/kg/day), azithromycin ( Zithromax ) (200 mg/kg/day), or rifabutin (40 mg/kg/day) as oral monotherapy; or (iii) all permutations of two-drug therapy or all three drugs in combination. azithromycin

After 4 weeks, quantitative blood cultures were obtained and the number of bacteria in liver and spleen was quantitated. Rifabutin sho inhibitory natural radioactivity only in the blood. Moxifloxacin sho inhibitory activity aldara at 0.5 microg/ml and higher. In conclusion, although a short oral treatment with azithromycin ( Zithromax ) was able to reduce the infection significantly, it was not able to cure the animals as effectively as the classic regimen with doxycycline administered for a longer period of time.. In an acute model evil, treatments acyclovir with doxycycline or doxycycline-streptomycin, for a period of 3 days, starting 1 day after lethal challenge, were able to protect all the mice. In a chronic model, constituent therapy 31 days after challenge, azithromycin ( Zithromax ) (10 days, 50 mg/kg/day) significantly reduced the infection (2.9 logs, day 48 post-infection). All groups contained at least 14 animals, and the control group received the drug vehicle. To assess the activity of moxifloxacin containing regimens in vivo, we infected C57BL bg( )/bg( ) mice with 3 x 10(7) MAC strain 101 bacteria intravenously.

Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin ( Zithromax ) in vitro and in vivo against Mycobacterium avium.Moxifloxacin activity against Mycobacterium avium complex (MAC) was evaluated in vitro against 25 strains. The MIC was determined to range from 0.125 to 2.0 microg/ml. One week later treatment was begun with the following. In contrast, only 50% of the mice treated with azithromycin ( Zithromax ) survived the challenge. Rifabutin did not add to the activity of any other single agent or two-drug combination. Similarly, the three-drug combination was not more active than azithromycin ( Zithromax ) alone in the spleen. Infection in mice.The activities of a short therapeutic regimen with azithromycin ( Zithromax ) and the classic treatment doxycycline with streptomycin were compared and evaluated in mice infected with Brucella melitensis. Moxifloxacin at both concentrations in combination with ethambutol was significantly more active than each drug alone.

The effectiveness of doxycycline (21 days, 50 mg/kg/12 hourly) was greater than azithromycin ( Zithromax ) (4.1 logs of reduction, day 48 post-infection), and when doxycycline was administered for a period of 45 days, all the animals were bacteriologically cured from day 78.


Ubicación:Madrid
Último acceso: viernes, 3 de abril de 2009, 17:25  (518 días 5 horas)

 
© 2007 Law and Corporate Tr. Almenara, 7 • 28760 Tres Cantos (Madrid) • 91 804 00 43 •
Usted no se ha autentificado. (Entrar)